SCHEMBL3341852

SCHEMBL3341852

CN[C@@H](Cc1c[nH]cn1)C(=O)OCCC(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3341681 0.99
SCHEMBL3340001 0.87 MAP3K7 (0.33)
Hydrochloric Acid SCHEMBL3336749 0.86 MAP3K7 (0.33)
SCHEMBL3337469 0.84 LMNA (0.39)
SCHEMBL3338064 0.84 CYP19A1 (0.35)
SCHEMBL19123170 0.83 SMN1; SMN2 (0.35)
SCHEMBL3337001 0.83 SMN1; SMN2 (0.35)
SCHEMBL13246853 0.83 SMN1; SMN2 (0.35)
SCHEMBL12765185 0.83 HDAC6 (0.36)
SCHEMBL2059164 0.83 HDAC6 (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2202227-B1 NOVEL HISTIDINE DERIVATIVE NIPPON ZOKI PHARMACEUTICAL CO (JP) 2013-11-20 EP disclosed
US-8324261-B2 Histidine derivatives NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) 2012-12-04 US disclosed
EP-2202227-A1 NOVEL HISTIDINE DERIVATIVE Nippon Zoki Pharmaceutical Co., Ltd. (JP) 2010-06-30 EP disclosed
US-20100152459-A1 NOVEL HISTIDINE DERIVATIVES NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) 2010-06-17 US disclosed